Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)

Clinical trial NCT04993586 · COMPLETED

Trial details

NCT number: NCT04993586
Sponsor: AnGes, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Lower Respiratory Infection

Start date: 2021-07-29
Primary completion: 2021-12-10
Enrollment: 422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.